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 Bone fractures are one of the most common injuries in the United States, 
encompassing 6.2 million incidences, and costing the healthcare system roughly $20 
billion annually. The majority of this cost falls upon a unique type of fracture known as a 
non-union fracture, defined by incomplete healing after 9 months. The economic burden 
in combination with the frequency by which these incidences occur offer a unique 
opportunity for research and improvement in the healthcare field.  
 Previous research on the fracture repair process showed that dietary deficiency led 
to delayed healing producing a rachitic-like effect on the endochondral bone formation 
process that occurs during fracture healing. This research will build off the understanding 
of hypophosphatemia on bone fracture repair utilizing a unique temporal clustering 
approach to assess changes in the transcriptomic expression within callus tissues of 
control fed and dietary phosphate restricted animals.  
 Using a temporal cluster modeling technique developed by our group (Lu et al. 
2019), twelve clusters were generated for the gene expression data extracted from the 
callus tissues of B6 strain mice at time points 3, 5, 7, 10, 14, 18-, 21-, 28-, and 35-days 
post fracture, in, control and phosphate restricted dietary groups.  Groupings of clusters 
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were used to establish the temporal expression patterns over the time course of healing 
and identify the movement of genes that changed their temporal expression patterns 
between the control and phosphate restricted diets. Biological process categories were 
established for each cluster, grouping using both Ingenuity Pathway Analysis (IPA) and 
the NIH DAVID Bioinformatics Database ontology assessment programs. Genes based 
on their association with four key tissue developmental processes in fracture repair, 
skeletogenesis, myogenesis, vasculogenesis, and neurogenesis were analyzed.  
 The analysis showed shifts to later peak expression times for all four categories. 
Further analysis illuminated three specific regulatory pathways that were significantly 
impacted by hypophosphatemia, Hippo and WNT signaling pathways and the circadian 
rhythm pathway while oxidative phosphorylation was both shifted and showed reduced 
expression. The shifts in expression time and level of these pathways demonstrate their 
importance to bone fracture repair and their impacts on mesenchymal stem cell 
differentiation. 
 From the data analysis it is clear that limiting dietary phosphate results in 
impaired mesenchymal stem cell differentiation caused by delayed Hippo and WNT 
signaling. Further it is evident that the processes of skeletogenesis, myogenesis, 
vasculogenesis, and neurogenesis are heavily interconnected, often showing overlapping 
genes through all four processes. Based on these shifts and impairments in specific 
signaling we identified novel mechanisms by which hypophosphatemia can impair 
fracture callus growth and development and delay healing. 
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Fracture healing is a unique and complex process that can be broken down into 
two main systems, endochondral bone formation, and intramembranous bone formation 
over a specific time period (Einhorn 2005). A serious complication is something 
considered to be a non-union fracture, defined as an incomplete healing 9 months post 
injury with no signs of healing determined by repeated radiological scans 3 months after 
(Panteli 2015). Bone fractures and osteoporotic injury are a $20 billion cost to the U.S. 
Healthcare system (Solomon 2014) and account for 6.2 million incidences in the United 
States alone each year (Dahabreh 2009). The economic consequences and the frequency 
by which fractures occur make it a topic in the medical field that is primed for analysis 
and improvement. Furthering the understanding of the process of fracture repair can ease 
economic constraints on lower income hospitals by reducing the incidence of non-union 
fractures and improving healing times will reduce loss in productive work productivity 
and disability after fracture injuries.  
There are two methods of bone formation that are capable of operating 
independently and cooperatively during fracture repair. Intramembranous ossification 




Figure 1: Intramembranous Bone Formation. This figure demonstrates the general steps 
of intramembranous bone formation.  (Taken from Galea 2021) 
 
These stem cells differentiate becoming osteoprogenitor cells, and then finally 
becoming osteoblast. These osteoblasts focus on what is known as the center of 
ossification, secrete collagen and produce unmineralized osteoid matrix. As the process 
progresses this area is infiltrated by calcium, mineralizing the area, trapping the 
osteoblasts, causing them to differentiate in osteocytes generating lacunar bone. A key to 
this process is the presence of high vascularization. The vasculature not only provides the 
nutrients, particularly calcium, but also introduces monocytes to the area which 
differentiate into osteoclasts, which break down the lacunar bone forming woven bone 
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(Dimitriou 2005) allowing later remodeling of the woven bone into its final lamellar 
structure of the original tissue.  
Endochondral bone formation begins similarly, with the condensation of 
mesenchymal stem cells, and is demonstrated in figure 2. However, instead of 
differentiating into osteoprogenitor cells, in endochondral formation they differentiate 
into chondrocytes. These chondrocytes generate a cartilage template around the fracture 
site, an avascular frame for which the repair process can begin. Once the template is 
formed, the remaining mesenchymal stem cells differentiate to form a vascular 
periosteum. This introduction of a vascular network allows for chondrocyte proliferation, 
expanding cartilage in a longitudinal direction. As the cartilage continues to expand the 
chondrocytes in the middle of the template undergo programed cell death, while the 
periosteum forms into a bone collar, stabilizing the cartilage and allowing for the vascular 
network to penetrate the cartilage introducing blood vessels, osteoblasts, and osteoclasts 
to the area to begin the ossification process as seen in intramembranous bone formation 





Figure 2: Endochondral bone formation. This figure demonstrates the general process of 
endochondral bone formation. (Taken from Galea 2021) 
 
However, instead of differentiating into osteoprogenitor cells, in endochondral 
formation they differentiate into chondrocytes. These chondrocytes generate a cartilage 
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template around the fracture site, an avascular frame for which the repair process can 
begin. Once the template is formed, the remaining mesenchymal stem cells differentiate 
to form a vascular periosteum. This introduction of a vascular network allows for 
chondrocyte proliferation, expanding cartilage in a longitudinal direction. As the cartilage 
continues to expand the chondrocytes in the middle of the template undergo programed 
cell death, while the periosteum forms into a bone collar, stabilizing the cartilage and 
allowing for the vascular network to penetrate the cartilage introducing blood vessels, 
osteoblasts, and osteoclasts to the area to begin the ossification process as seen in 
intramembranous bone formation (Colnot 2005).  
 
Timeline of Fracture Repair 
 
To understand the intermingling of these two processes mouse models are used 
with fractures generally being induced in the femur.  
As noted, bone formation occurs over a specific period of time. In this case, 
periods of time will be discussed based on the mouse model. 
In the first 7 to 10 days of fracture healing, the process of chondrogenesis begins, 
next to the fracture while osteoprogenitor cells begin under the periosteum (Einhorn 
2005). As with most injury, inflammatory response begins during the early phases, which 
triggers the invasion of macrophages, polymorphonuclear leukocytes, and lymphocytes. 
At day 14 more bone forms under the periosteum and the cartilage begins to 
calcify. This calcification is conducted by the chondrocyte membrane delivering calcium 
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from the mitochondria of hypertrophic chondrocytes into the extracellular matrix, 
resulting in the formation of what is known as a hard callus, a cartilaginous mass that 
bridges the fracture (Einhorn 2005). Once critical mass is reached the callus will begin to 
calcify, as chondrocytes within the callus begin secreting phosphatases (Einhorn 2005). 
The secreted phosphate will precipitate with the delivered calcium forming cartilage, and 
secreted proteases, will degrade proteoglycans inhibiting mineralization, allowing 
chondrocytes to control the mineralization process (Einhorn 2005).  
By day 21, the majority of the callus has calcified. The calcified callus becomes a 
major target for chondroclasts, which degrade the calcified cartilage, signaling the 
penetration of the area by blood vessels (Einhorn 2005). These blood vessels bring 
mesenchymal stem cells to the area, which differentiate into osteoprogenitor cells and 
ultimately osteoblasts. These osteoblasts begin the process of replacing the calcified 
cartilage. As this replacement occurs, the mineralized matrix is resorbed, and the 
chondrocytes removed (Einhorn 2005). 
During days 28 to 35, the calcified cartilage combines with woven bone from 
osteoblasts. The remodeling of the callus begins with the osteoclasts converting the 
woven bone and calcified cartilage into lamellar bone capable of supporting weight 
(Einhorn 2005).  
The transition from cartilage to bone is key in the healing process when 




Each of these periods throughout the repair process show differing peak genetic 
expressions. In the case of this research, the first will be considered overall decreasing 
expression (due to the immediate peak and then decreasing throughout the rest of the 
process), early peak time expression, middle peak time expression, and late peak time 
expression respectively.  
 
Impairments of the Repair Process 
  
While the repair process seems direct, it is easily impaired by outside factors. For 
example, diabetes mellitus can cause impaired fracture healing due to premature 
resorption of the cartilaginous callus (Kayal 2007). The introduction of non-steroidal 
anti-inflammatory medications limit prostaglandins, which are key to the fracture repair 
process, thus suggesting avoidance of the medication (Zhang 2002). Even disruptions in 
circadian rhythm have been linked to mutation of the histone methyltransferase EZH2, 
which can control overall skeletal growth (Noguchi 2018).  
Phosphate specifically has been shown to be a key to the fracture repair process. 
Hypophosphatemia is associated with rachitic disorders (Linde 2001, Robinson 2004), 
such as rachitic expansion of the hypertrophic chondrocyte layer in the growth plate as a 
consequence of impaired apoptosis of cells (Sabbagh 2005). Further molecular analyses 
have shown increasing extracellular phosphate results in an activation of the 
mitochondrial apoptotic pathway in hypertrophic chondrocytes (Wigner 2010). This is a 
key process in endochondral bone formation, suggesting that while phosphate is needed 
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for formation of the mineralized matrix, it is a key regulatory mechanism for 
hypertrophic chondrocyte differentiation and subsequent initiation of mineralized 
cartilage tissue resorption (Wigner 2010).  
However, while it is evident that that phosphate is impacting repair, further 




SPECIFIC AIMS AND OBJECTIVES 
 While previous research has demonstrated the impacts of hypophosphatemia on 
fracture healing, this research will look to expand on the understanding of its impact by 
examining the global transcriptomic landscape within fracture callus tissues.  A unique 
temporal clustering method (Lu 2019) will be used to assess changes in the 
transcriptomic expression within callus tissue mRNAs isolated from control and dietary 
phosphate restricted fed mice. This methodology will also allow for a broad 
understanding of how dietary phosphate levels effect fracture healing and how phosphate 







 All animal experiments were approved by the Institutional Animal Care and Use 
Committee at Boston University. Total RNA had been prepared from bone fracture callus 
tissues from N=6 mice per each time point. N=3 samples of RNA were then made for 
each time point by a randomized pooling of 2 samples per group of the six animal 
samples per time point. All microarray laboratory procedures were performed at the 
Boston University Microarray and Sequencing Resource. Methods for sample processing, 
normalization of microarray data, and quality control measures for examining for batch 
effects and comparing individual samples by principal components are as previously 
described  (Noguchi,et al 2018). Raw CEL files and RMA-normalized, ComBat-adjusted 
values were archived in the National Center for Biotechnology Institute (NCBI) Gene 
Expression Omnibus Repository (Series GSE99580). 
The analysis completed in this research is based on the genetic clustering method 
reported in Lu et al. 2019. This method is based on assessing N temporal gene-expression 
profiles at T time points. Each of these time points then generates R replicates resulting in 
each temporal gene expression having T x R measurements (Lu 2019). Using Gaussian 
finite mixture modeling generates the clustering of the N gene-expression profiles into K 
groups that predicts the total number of temporal profiles that best fits the gene 
expression data.  
Lu et al. 2019 assumes that the number of replicates, R, for each gene is 1, for 
each time point, T. Lu continues that Gaussian mixture models assume temporal 
expression profiles for each cluster are generated using one component of a mixture of 
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Multivariate Normal distributions (Lu 2019). From here the kth cluster is the group has a 
probability of occurring equal to αk=P(zi=k). In this formula, z is missing cluster label for 
the temporal profile of gene I and ∑Kk=1αk=1 (Lu 2019). Based on the parameters for each 
cluster, a probability density function can be determined, suggesting that when considering 
all parameters the unconditional probability density function for yi can be represented as a 
weighted sum (Lu 2019). Using the expectation maximization algorithm (Dempster 
1977), the maximum likelihood estimates for each parameter can be determined (Lu 
2019). By then extending this formulation to account for a relationship with T-time points 
using polynomial regression models, the polynomial regression models can be solved 
using the expectation maximization algorithm (Lu 2019).  
 However, in most biological cases there are numerous replicates for each time 
point measure for gene-expression. Considering this concept of R replicates, for each 
time point T, T x R measurements are generated (Lu 2019). Using a mixed effects linear 
regression model accounts for the variability between the replicates for each time point 
by giving each gene for the time point its own intercept and/or slope (Celeux 2005, Ng 
2006). Incorporating this mixed effect linear regression model with a random effects 
regression model maximizes the opportunity to detect unobserved missing data when 
used with the expectation maximization algorithm (Lu 2019). Further, a penalty term is 
added to the growing expectation maximization algorithm model, in order to account for 
increased data size and complexity, thus simplifying analysis (Lu 2019).  
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 This model is then initialized by setting the number of clusters equal to the 
number of temporal gene expression profiles in the given data (Lu 2019). Cluster 
parameters are set using a fixed effect polynomial regression model, determining the 
median residual error for the gene and replicate models analyzed (Lu 2019). Finally the 
fixed and mixed effect polynomial order is determined prior to running the algorithm and 
thus applied to all clusters (Lu 2019). 
 The modeling technique described by Lu, while complex, was validated through 
numerous simulations of increasing sample size, and increasing complexity. The results 
were then compared to previously establish multi-step clustering methodologies. 
Laboratory temporal gene expression data was conducted and a likelihood ratio test 
performed to determine if the Lu modeling technique was a better fit than the previously 
established modeling techniques using an alpha-level of 0.01 (Lu 2019).  
 This methodology was then applied to the given dataset for this study, 
establishing the 12 clusters for both the control and experimental diet groups for the B6 
mouse strain. 
After the temporal clustering of various gene groupings based on the temporal 
analysis were completed, two different software tools were used to assess biological 
ontologies and biological pathways associated with the various gene groups. In the first, 
Ingenuity Pathway Analysis (IPA) was used for the analysis of the baseline clusters and 
groupings generated to assess significant movement based on the dietary changes. A core 
analysis was run on each cluster. This identified the various biological functions and 
canonical pathways that were associated with a given clusters and the genes associated 
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with these functions and pathways. For the core analysis only specific pathways and 
functions showing significance at (p<0.05) were considered. 
 The second method that was used was the DAVID Bioinformatics resource 
(https://david.ncifcrf.gov/home.jsp) (Hosack 2003, Huang 2007) This tool was used to 
identify pathways specifically associated with the development of four specific tissue 
types (muscle, skeletal tissues, neural tissues and vascular tissues.  Only pathways with a 






Applying the temporal modeling to the control and phosphate restricted diet 
transcriptomic data across the 35-day time course produced twelve clusters.  Two sets of 
identical clusters for both the control and phosphate restricted diet are seen in Figure 1. 
The mean expression	of	all	genes	in	the	cluster	is	depicted	by	the	red	line. While the 
clustering method sorts the total data sets from both control and phosphate restricted 
genes into the same twelve clusters a specific gene was assigned to a given cluster 
dependent on if it was from the control or phosphate restricted data set. Thus some genes 
for both control and diet restricted groups will be in the same cluster while others will be 
shifted into a different cluster.  
 







By comparing the list of genes expressed in clusters for the control and phosphate 
restricted groups a cross tabulation table can be generated. This table can be used to 
determine the total number of genes that shifted from cluster to cluster based on the diet.   
For example, there were 648 genes that were in cluster 1 for both the control and 
phosphate restricted diet however 46 genes that had shifted from cluster 1 of the control 
diet, that were now in cluster 2 for the phosphate restricted diet and 66 in cluster 3 etc.  
 
Table 1. Cross-Tabulation Table. This table is the cross tabulation of all the genes 
analyzed and shows how genes changed based on diet.   
  
The graphical appearance of each of the twelve clusters was next used to identify 
cluster groups within specific temporal expression periods which show correspondence to 
the major biological process associated with fracture healing (Table 2).   
 
Phosphate 
Res      Diet         
  1 2 3 4 5 6 7 8 9 10 11 12 
control 1 648 46 66 10 94 124 81 22 0 91 0 26 
Diet 2 160 258 52 44 150 99 21 5 0 1 0 1 
 3 359 127 302 7 76 324 615 79 1 131 1 122 
 4 40 78 8 112 574 113 2 0 0 0 0 0 
 5 26 5 3 4 91 58 4 2 0 0 0 0 
 6 18 3 8 6 56 437 82 14 0 10 0 3 
 7 19 1 64 1 0 52 2207 117 24 229 41 210 
 8 110 3 98 0 7 104 2544 157 4 346 34 240 
 9 0 0 1 0 0 0 13 0 12 20 40 17 
 10 24 1 21 1 0 13 193 21 24 363 108 127 
 11 0 0 1 0 0 0 78 6 770 130 1947 250 




Table 2: Clusters groups showing similar temporal expression profiles. This table 
demonstrates the established grouping and the appropriate clusters for those groupings. 
 
This overview of the data shows the cluster groups within a temporal expression periods 
that correspond to specific period s of fracture healing over the 35 days period.  This 
simplification then enables the significant pathways in the bone fracture repair process to 
be dynamically examined and identified within specific temporal period during fracture 
repair.  
 By grouping the genes in this manner, it offers the opportunity for significant 
gene groups in the bone fracture repair process to be dynamically examined and 
identified within specific temporal period during fracture repair. Using the cross 
tabulation table the total number of genes that shifted from cluster to cluster based on the 
diet within specific temporal period could be identified.  For example, there were 2144 
genes that were in cluster 3 for the control diet. Genes in this cluster have a peak 
expression of 9 days and contain the large majority of genes associated with 
chondrocytes and cartilage development.  In contrast when placed on the phosphate 
Expression Peak Clusters    
Overall Decreasing Expression Cluster 1    
Early Peak Expression  (Endochondral Period) 
Between days 5 -12 
Cluster 2 Cluster 3 Cluster 4 Cluster 5 
Middle Peak Expression (Cartilage Resorption 
First Bone Formation) Between days 14-21 
Cluster 6 Cluster 7 Cluster 8  
Late Peak Expression  (Extended bone 
Remodeling Cortical and Marrow Bone 
Formation)   Between days 21-35 
Cluster 9 Cluster 10 Cluster 11 Cluster 12 
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restricted diet only 302 genes show a common temporal expression with the control 
grouping while 1355 genes show a shifted expression to clusters with later peaks of 
expression while the remaining genes shifted to an early period of expression. Thus by 
analyzing what gene ontologies and signaling pathways these genes belong to, we can 
deduce how phosphate restriction has effected the callus tissues’ developmental 
progression and identify the primary regulatory mechanisms that are mediating these 
temporal changes. Specific groupings of genes that are shifted from the major expression 
periods are colored coded in the cross-tabulation table and summarized in Table 3. 
Table 3. Group Comparisons. This table shows the color coding for table 1. Color coding 
presents genes grouped together that showed similar types of temporal shifts. 
Group 1: Same Cluster 
Group 2: Decreasing vs. Early peak 
Group 2.1: Early peak vs. Decreasing  
Group 3: Decreasing vs. Middle peak 
Group 3.1: Decreasing vs Middle peak 
Group 4: Early peak vs Middle peak and Late (1579 genes)  
Group 4.1: Middle peak vs. Early peak  
Group 5 Decreasing: vs. Late peak 
Group 5.1: Late Peak vs. Decreasing (91607 genes) 
Group 6.1: Early peak vs Late Peak 
Group 7: Middle vs Late peak (1141 genes) 
Group 7.1: Late Peak vs Middle Peak (1607 gen) 
 
 These expression peaks were then compared to each other for the groups of genes 
that showed specific shifts in peak expression time based on diet, thus indicating 
particular genes that would be influenced by a change in dietary phosphate levels. The 
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aggregate gene groups were then placed into categories based on biological process using 
the DAVID ontology tool that associated with the development of four major tissue: 
myogenesis, skeletogenesis, neurogenesis, and vasculogenesis. It should be noted that 
genes that play a role in multiple categories were divided equally between the categories. 
For example, a gene that is expressed in both myogenesis and skeletogenesis counts as 
half a gene for each category. Using these four groups allows for the vast number of 
shifted and expressed genes to be viewed in a manner that relates their expression to a 
specific tissue. This will demonstrate the impact of phosphate restriction on these key 




 Using the DAVID program to identify specific ontologies associated with the 
various tissues the number of genes expressed at the given peak expression time point for 
those tissues could be identified.  Our initial focus was on biological processes of 
myogenesis, skeletogenesis, neurogenesis, and vasculogenesis, as the primary tissues that 
would have been injured by the blunt trauma of fracture and involved in tissue 
regeneration.  Specific genes were given fractional values if they overlapped between 
biological processes.  Myogenesis has 104.83 genes with an overall decreasing 
expression, 72 genes had an early peak expression time point, 13 genes with a middle 
peak expression time point, and 0 genes with a late peak expression time point. 
Skeletogenesis has 24.67 genes with an overall decreasing expression, 107.34 genes with 
an early peak expression time point, 43.67 genes with a middle peak expression time 
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point, and 0 genes with a late peak expression time point. Neurogenesis has 98.33 genes 
with an overall decreasing expression, 400.67 genes with an early peak expression time 
point, 353.17 genes with a middle peak expression time point, and 0 genes with a late 
peak expression time. Vasculogenesis has 41.17 genes with an overall decreasing 
expression, 110 genes with an early peak expression time, 42.17 genes with a middle 
peak expression time, and 0 genes with a late peak expression time. 
 
Effect of Phosphate Restriction on Specific Tissue Development  
A comparison of how specific tissue development was impacted when placed on a 
phosphate restricted diet was then assessed by examining how they shifted. When placed 
on the phosphate restricted diet myogenesis had 27 genes shift to an overall decreasing 
expression, 15.58 genes shift to an later peak expression time, 4 genes shift to a middle 
peak expression time, and 0 genes shift to an early peak expression time.  Skeletogenesis 
had 0 genes shift to an overall decreasing expression, 31.08 genes shift to a later peak 
expression time, 0 genes shift to a middle peak expression time, and 0 genes shift to an 
early peak expression time. Neurogenesis had 67 genes shift to an overall decreasing 
expression, 118.42 genes shift to a later peak expression time point, 0 genes shift to a 
middle peak expression time point, and 0 genes shift to a late peak expression time. 
Vasculogenesis had 0 genes shift to an overall decreasing expression, 27.92 genes shift to 
a later peak expression time point, 0 genes shift to a middle peak expression time point, 




Table 4. Baseline peaks and number of genes shifted. This table demonstrates the total 
number of genes for a given biological process with the peak time expression in the 
baseline expression peak columns. The number of genes that shifted to a given expression 
peak consists of the number of genes that moved to the given expression based on the 
biological process.  
 
 Baseline Shifted 



































































































1indicates the number of genes as a percentage of the total number of genes with that 
expression peak for the biological process 












 While the breakdown of genetic expression based on the biological process is 
useful, further analysis using IPA and DAVID was run on the groups and baseline 
clusters to understand various canonical pathways and genes that may not have been 
captured directly in the observed processes. The vast majority of the pathways produced 
by IPA and DAVID had no impact on bone repair or bone growth and were removed 
from the analysis.  
 Based on the IPA analysis of the baseline clusters there is only one canonical 
pathway that had an impact on fracture repair. IPA showed that cluster 8 was significant 
for the oxidative phosphorylation pathway.  
 Based on the DAVID analysis of the baseline clusters, cluster 2 was significant 
for cartilage and skeletal development, this is captured in the data above as cluster 2 has 
an early peak expression time. Clusters 5 and 6 were significant for genes involved in 
tissue development, again captured in the data above as cluster 5 has an early peak 
expression time and cluster 6 has middle peak expression time. Cluster 8 was significant 
for the oxidative phosphorylation pathway, the same as the IPA analysis had. 
  After establishing a baseline, the group that detected shift were entered into both 
systems. Again, numerous pathways that the systems produced were not significant to the 
bone fracture repair process and were removed from the analysis. Based on the IPA 
analysis of the groups, oxidative phosphorylation shifts in group 3, from a middle peak 
expression time to an overall decreasing expression. Further it shows that in group 6 
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circadian rhythm shifts from an early peak expression time to a later peak expression 
times. 
 Based on the DAVID analyses it is seen that WNT signaling shifts in group 2, 
from an early peak expression time to an overall decreasing expression. Group 4 showed 
a shift in tissue development from an early peak expression time to a late peak expression 
time. Group 6 continued to show a shift in circadian rhythm from an early peak 
expression time to a late peak expression time. 
 Finally due to its integration with almost every pathway a DAVID analyses was 
conducted to determine the shift of the metabolite pathway. Similar to most other 
pathways, when phosphate was restricted the metabolite pathway showed a shift from an 
early peak expression time point to a late peak expression time point.  
Based on the DAVID pathway analysis the metabolite pathway was significantly 
involved in the control of the TCA cycle and nucleotide formation. It was evident that a 
large number of portions of the pathway were impacted by phosphate restriction however 
those of interest in the case of this analysis were the TCA cycle and nucleotide formation 






Hypophosphatemia has a detrimental impact on the bone fracture repair process.  
Simply based on the data gathered here, shifts in processes clearly significant to the 
fracture repair cycle demonstrate changes in their peak expression time points.  
 In examining skeletogenesis a shift from earlier to a middle peak period of 
expression time was observed for a number of skeletal genes. While this biological 
process processes were observed for both chondrogenic and osteogenic cells consistent 
with our previous published studies (Noguchi et al 2018).  However, the 
interconnectedness of these pathways, myogenesis, vasculogenesis, and neurogenesis, 
would further suggest this shift in skeletogenesis to an early peak expression time.  
The decrease in mesenchymal stem cell differentiation caused by the phosphate 
restricted diet would trigger a response to increase the factors that can drive cellular 
differentiation. Hence, a shift to later expression of myogenic, vasculogenic, and 
neurogenic cells would be expected as all of these pathways interact to play key roles in 
cellular differentiation. Myogenesis promotes the vascularization of the area which 
promotes oxygen and nutrient flow to increase cellular differentiation and the earlier shift 
in neurogenic signaling continues to promote cellular differentiation. The interplay of 
these three biological processes would suggest that genes responsible for skeletogensis 
would also shift to a later peak expression, as cellular differentiation would begin later 
and hence the expression of bone regeneration specific genes would also need to be 
expressed later.  
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This interconnectedness is further confirmed by the presence of numerous 
overlapping genes between the processes. Thus, not only suggesting that they work 
together to promote the fracture repair process, but also suggesting that any shifts we are 
seeing in one process, are most likely seen in the other processes as key genes overlap.  
While it is clear that these shifts impair the fracture repair process, what is unclear 
is how these shifts relate to decreased size in callus formation (Wigner 2010). As 
mentioned, previous research points to the impaired signaling of BMP, WNT, and FGF 
and the detrimental impact this has on fracture repair. Direct impairment of these process 
would cause a decrease in the callus size. However, the shift of the other processes would 
be hypothesized to counteract these impaired signaling pathways. When considering the 
results of this research with previous evidence, it is clear that while these processes are 
interconnected, phosphate plays a directly role in the impairment of the signaling 
pathways of BMP, WNT, and FGF. Regardless of the compensation from other 
biological processes, impairment of these signals will limit callus growth. 
The shifts observed and theories on phosphates impact on signaling in the 
biological process data are further supported by the canonical pathway shifts seen in the 
IPA and DAVID analyses. As shown by IPA oxidative phosphorylation begins in cluster 
8, which demonstrates a middle peak expression time. It is then seen to shift as part of 
group 3, which indicates a shift from a middle peak expression time to an overall 
decreasing expression. Previous research suggests that when stem cells are differentiating 
there is a shift from glycolysis to the oxidative phosphorylation pathway, indicating that 
the oxidative phosphorylation pathway and mitochondrial dysfunction can impair 
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mesenchymal stem cell differentiation. The shift demonstrated in this data confirms the 
important of oxidative phosphorylation for stem cell differentiation, and the overall 
decreasing nature of cluster 1 in the phosphate restrict diet suggests that genes involved 
in oxidative phosphorylation are not being expressed at nearly the same level as they 
were previously in cluster 8 at baseline. Hence, a shift to an early peak expression with an 
overall decrease in total expression would conclude that the phosphate restriction in 
impairing oxidative phosphorylation, limiting mesenchymal stem cell differentiation, 
decreasing the possible callus size. 
These concepts are again confirmed by the DAVID analyses. DAVID showed the 
same WNT shift in group 2, from and early peak expression time to an overall decreasing 
expression, a shift in tissue development in group 4, from middle peak expression to an 
early peak expression time, and a shift in circadian rhythm in group 6, from a late peak 
expression to and early peak expression time.  
This shift seen in WNT signaling is confirmed by the shift seen in the biological 
process data, where neurogenesis has genes shift to overall decreasing expression time 
points. As mentioned WNT signaling promotes mesenchymal stem cell differentiation, 
which is impaired by phosphate restriction, and therefore would see a shift to an overall 
decreasing expression time point. Again, when considering the given cluster data for 
cluster 1 in the phosphate restricted diet (figure 3) it can be seen that the overall 
expression levels of the data in this cluster is lower than the expression levels for all other 
clusters, indicating that WNT signaling is impaired when phosphate is restricted. This is 
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While not every gene in the WNT signaling pathway it directly impacted, it is 
clear that phosphate restriction significantly impacts the pathway. Decreased overall 
expression of the WNT signaling pathway would impair fracture repair.  
Further it is seen that this phosphate restriction impacts other key pathways such 
as that TGF Beta signaling (figure 5) and HIPPO signaling (figure 6).  
TGF Beta signaling is key to osteoblast differentiation and bone formation (Chen 
2012). Previous research has already shown that impairment of this pathway impacts 
bone fracture repair (Wigner 2010). Further, there is close interaction between the 
pathways of WNT signaling as well as TGF Beta/BMP signaling (Wigner 2010). Thus it 
impairment of one pathway would suggest impairment of the other pathway. When 
considering figure 5, it is clear that phosphate restriction impairs TGF Beta/BMP 
signaling, offering further explanation for the impaired fracture repair mechanisms, that 
coincide with the knowledge that phosphate restriction delays the fracture repair process 
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Finally, the HIPPO signaling pathway plays a key role in osteoblastic bone 
formation and osteoclastic bone resorption, as well as the mechanisms of bone 
metabolism and disease (Yang 2018).  Again it would be assumed that impairment of this 
process would impact bone formation and fracture repair. This is confirmed when 
considering figure 6 as entire portions of the pathway are shifted based on changes in 
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The shift is tissue development seen in group 4 from a middle peak expression to 
a later peak expression time is less specific but does coincide with the biological process 
shift data. Tissue development could encompass myogenesis, skeletogenesis, or 
vasculogenesis, all of which showed a shift from middle peak expression to an early peak 
expression time, thus confirming the ideas in the shift data.  
Finally, the shift seen in circadian rhythm connects with the shift seen oxidative 
phosphorylation. Circadian rhythm has been shown to have significantly altered 
expression in the fracture callus of mice and is linked to oxidative metabolism and 
skeletal growth in animals (Noguchi 2018). Based on the previous research it is seen that 
circadian rhythm takes is expression signaling from the expression levels of oxidative 
phosphorylation (Noguchi 2018). This would suggest that there should be a slight 
difference in the peak expression times between oxidative phosphorylation and circadian 
rhythm. This is confirmed by the fact that oxidative phosphorylation shifts to an overall 
decreasing expression and circadian rhythm shifts to an early peak expression time point. 
The impacts on circadian rhythm are further confirmed by the DAVID pathway analysis 
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The data gathered in this research confirms previously established research and 
offers direct changes in time point of peak expression and genetic expression levels based 
on phosphate restriction. These shifts in time point and overall expression levels offer 
opportunities for therapeutic targets during the fracture repair process. Later research can 
further differentiate the biological process groups and offer more insight in shifts of 
particular genes during the fracture repair process. In combination with further 
differentiation of the biological processes’ groupings, comparison to varying mouse 
strains can confirm these shifts. By comparing to various mouse strains using both the 
biological process categories and further differentiated categories it can clarify which 
particular genes are being impacted by phosphate restriction thus impairing the fracture 
repair process.  
First consider skeletogenesis. It is evident from previous research that under 
ricketic conditions there is significant retardation in the bone fracture repair process 
(Noguchi 2018). This is supported through the data gathered and analyzed in this trial. As 
demonstrated, phosphate is key to numerous pathways that have significant impact on 
signaling for cellular differentiation and the bone formation process. WNT, HIPPO, and 
Circadian rhythm have all been shown to have major implications during osteogenesis 
and have shown that during phosphate restriction are drastically impacted. This would 
offer explanation as to the shift to later expression of the genes responsible for 
skeletogenesis.  
As discussed, WNT signaling promotes mesenchymal stem cell differentiation. If 
the expression of genes responsible for WNT signaling is decreased this would offer 
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minimal differentiation. This lack of stem cell differentiation would delay the beginning 
of chondrogenesis and osteogenesis, the main pathways of skeletogenesis, leading to the 
retardation in bone formation implicated by phosphate restriction.  
This concept is supported again by the shift seen in the HIPPO pathway. One of 
the key steps in bone formation is interaction between the osteoblasts and osteoclasts, 
which generate and resorb bone respectively. This homeostatic process is one of the final 
steps in bone formation and controlled directly by the HIPPO pathway. As seen in the 
figure, phosphate drastically shifts the HIPPO signaling pathway, which would in turn 
justify the shift seen in the skeletogenesis pathway. 
The shift noted in skeletogenesis is support by the shift seen in the circadian 
rhythm pathway. Previous research has shown that circadian rhythm is directly linked to 
oxidative phosphorylation and skeletal growth (Noguchi 2018), therefore a shift in 
circadian rhythm could be matched by a shift in oxidative phosphorylation. Thus with a 
decrease in the amount of available energy, the bone formation process and eventual 
callus size would be heavily impacted.  
Next consider myogenesis and vasculogenesis, previous research has shown that 
myogenic gene expression in the area of the fracture is key for vascular penetration later 
in the cycle (Davis 2015), and that vasculogenesis is a highly regulated portion of the 
bone fracture repair cycle (Hankenson 2012). Simply between these two pathways, it 
would be expected that a shift in myogenesis would be paired with a shift in 
vaculogenesis, which is confirmed through the data of this analysis.  
 
35 
On a cellular level, vasculogenesis is controlled by growth factors and stromal 
cells (Hankenson 2012). The shift to a later expression by vasculogenesis is further 
confirm when considering the shifts seen in TGF Beta signaling, a key growth factor 
signaling pathway. Again, the shift in vasculogenesis to a later time point, which would 
be responsible for bringing the chemical signaling necessary for bone formation and 
calcification to the fracture area, would then cause a shift in skeletogenesis to a later time 
point.  
Lastly when considering neurogenesis it is again noted that the majority of the 
genes expressed in the pathway shift to a later peak expression time. BMP signaling is 
directly related to the differentiation of stem cells into osteopathic derivatives (Wigner 
2010). WNT signaling acts, similarly, promoting the osteogenic differentiation of 
mesenchymal stem cells (Houschyar 2019). FGF plays a key role in the development of 
and regeneration of various tissues, particular bone regeneration (Charoenlarp 2017). 
These previous studies clearly demonstrate the impact of neurogenic pathways on cellular 
differentiation, a key component of the bone fracture repair process. Which confirms that 
a shift of neurogenesis to a later time point, would further confirm the shift seen in 
skeletogenesis.  
When considering the pathways and shifts seen in the biological processes, it is 
evident that bone fracture repair is a heavily complex process that intertwines with 
numerous pathway and processes. Shifts in cellular differentiation, chemical signaling, 
and thus available material to conduct fracture, confirm the retardation noted in the bone 
fracture repair process.  
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Finally while there are potential explanations for almost every shift seen 
throughout this analysis, the most practical may be the shift seen in the metabolite 
pathway. The metabolite pathway is crucial in the formation of nucleotide and the TCA 
cycle. Without the building blocks of genetic material and the energy to conduct 
pathways it is comprehensible why bone fracture repair and bone formation may be 
hindered if the metabolite pathway is hindered for any reason.  
In this case it is noted that the metabolite pathway shifts from an early peak 
expression time to a later peak expression time. The main window for chondrogenesis 
and osteogenesis occurs in the first fourteen days as mentioned previously. A lack of the 
crucial building blocks and energy needed for the cell during this time would impair the 
fracture repair process.  
However, while it would impair the process, it further offers and explanation for 
why there is a decrease in the size of the callus formed while on a phosphate restricted 
diet. Again it all hinges on the lack of available nucleotides and energy in the cell to 
promote the necessary cell differentiation and tissue formation during the process.  
The interconnection with the metabolite pathway and numerous other cellular 
pathways offers an interesting and simplistic explanation for the impairment of fracture 
repair and decreased callus size formation. Without changing any other pathways, by 
simply impacting the pathway that helps build the most basic units for protein formation 
and genetic expression you would significantly decrease the opportunity to quickly and 
effective repair fractures or form bone.  
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 In total, the bioinformatic analysis with this genetic expression data confirms 
previous research, showing that when phosphate is restricted, bone fracture repair and 
bone formation shows significant retardation.  
 
Further Research 
 While the data analyzed here confirms previous research on the impacts of 
phosphate on bone fracture repair and bone formation, it may not be capturing the full 
picture. In the case of this analysis, the methodology for establishing the groupings and 
running the comparisons may in fact be limiting the amount of gene shifts that are being 
captured and further being statistically significant. 
 In order to capture the full understanding picture of the genetic shifts based on 
phosphate restriction, the shift grouping analysis need to capture the largest number of 
shifted genes possible. Thus future research should potentially follow a new 
methodology.  
 Based on the modeling of Lu et. Al 2019, clusters are created based on genes that 
follow similar expression patterns. In this analysis those genes were then grouped based 
on general peak expression time, early, middle, and late peak genetic expression time. 
These peak groupings were used to establish baselines, and then were compared to the 
same groupings to assess shift. However, while this offered a simple analysis, it didn’t 
necessarily capture all shifting genes and pathways. 
 As mentioned the bone formation and fracture repair process has peak 
chondrogenesis and osteogenesis for the first 14 days. When considering the clusters that 
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were placed into the early genetic peak expression time group, cluster 2, 3, 4, and 5, it is 
noted that they have varying peak expression days. Cluster 2 has a peak expression at day 
7, cluster 3 at day 9, cluster 4 at day 10, and cluster 5 at day 11. While the max difference 
between these clusters of 4 days doesn’t seem like a lot, when considering that the 
majority of chondrogenesis and osteogenesis occurs during the first 14 days, a shift of 
even a half a day would have a drastic impact bone fracture and bone formation.  
 Further analysis should seek to make the grouping more time specific. Instead of 
creating a large group of simply early peak expression, the groupings should be based on 
a specific peak expression time point. In this case seeing as each cluster has its own peak 
expression time point, they should each be considered as their own baseline group. 
Shifting from there should be considered any later time point.  
 By having the shift group be any later time point it allows for the maximum 
amount of shift to be detected and maximizes the number of genes of bioinformatic 
analyses. Furthermore, it allows for the entire necessary pathway and genetic expression 
profile to be captured in the shift group.  
When again considering the early peak expression time group, it is seen that this 
spans clusters 2, 3, 4, and 5 and therefore days 7, 9, 10, and 11 respectively. It is 
understood that the switch between chondrogenesis and osteogenesis occurs between 
days 9 and 10. Therefore, based on the groupings established in this analysis the 
osteogenesis pathway is broken between the early peak expression time group and the 
middle peak expression time group. While this may be captured in the baseline or shift 
data, by breaking the pathway and genetic expression over two groups it decreases the 
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number of genes available for analysis. This decreased number of genes may allow for 
the shift to be detected in the analysis, but it may not be registered as significant, and 
would therefore be disregarded. 
For example, to allow a more robust analysis, baseline genetic expression and 
pathways should be established using each individual cluster, in the case of this example 
consider cluster 2. From there shift analysis should be run by considering if any of the 
genes from cluster 2 shifted to anything later. This creates the largest number of genes 
available for analysis and will capture any significant shift. This process should be 
continued for each cluster, continuing to exam only shifts for later expression.  
Once all clusters shifting to a later time point is assessed, the same process should 
be considered for shifts to an earlier time point. While this in contrary to the 
understanding of how phosphate impacts the bone formation process, it may suggest 
disease pathways that are shifting to early expression as the repair process slows and 
shifts later.  
Ultimately after analyzing the data in this manner, the results should be verified 
against other genetic variations of mice. Comparison to other strains of mice offers two 
new points to consider. First, increase in genetic variation offers and increase in the 
number of clusters developed from the Lu et al. 2019 methodology. This is overcome by 
grouping the clusters based on matching peak expression time points. For example, 
anything that peaks on day 2 should be considered together. Second, it offers the 
opportunity for other genes to be shifted. If this is the case, it can further the 
understanding of how phosphate is impacting the fracture repair process.  
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By utilizing the Lu methodology with groupings that maximize the number of 
genes available for shift analysis, it offers the opportunity to get a complete picture of 
how the dietary phosphate is impacting genetic expression. Continuing analysis to assess 
both shifts to later expression and earlier expression not only offer insight into the 
fracture repair process but can suggest possible disease pathways that may arise from 
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